Blood Hemoglobin: A Possible Predictor of Central Venous Catheter-Related Thrombosis in Parenteral Nutrition

1985 ◽  
Vol 9 (4) ◽  
pp. 471-473 ◽  
Author(s):  
Stefan Jacobson ◽  
Bo Brismar
2020 ◽  
Vol 25 (1) ◽  
pp. 16-26
Author(s):  
Olivia Saqui ◽  
G. Fernandes ◽  
J. Allard

Highlights A lower CVC infection rate suggests an improvement in practice and education. CVC infection remains a complication that often requires significant health care resources. Use of tunneled CVC and patient education on catheter care reduces CVC infection rates.


Author(s):  
Daniel Marks ◽  
Marcus Harbord

Venous catheter-related problems Other complications of parenteral nutrition Problems with enteral tubes Re-feeding syndrome ● Above all else, ‘if the gut works, use it’. Only consider IV feeding if patients are likely to be without enteral nutrition for 〉5d. ● Central venous catheter feeding (i.e. catheter tip in SVC, IVC, or right atrium) preferred to avoid thrombophlebitis from hyperosmolar feeds. Well-managed central catheters can be left ...


2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Tomoko Yamashita ◽  
Ayako Takamori ◽  
Akira Nakagawachi ◽  
Yoshinori Tanigawa ◽  
Yohei Hamada ◽  
...  

Abstract To determine the prophylactic effect of using combined 1% alcoholic chlorhexidine gluconate and chlorhexidine gel-impregnated dressings (CGCD) on catheter-related thrombosis (CRT) in critically ill patients. This retrospective cohort study was performed in an intensive care unit from November 2009 to August 2014. The CRT incidence diagnosed with ultrasound examination was compared between patients applying CGCD and combined 10% aqueous povidone-iodine and standard transparent dressings (PITD) after central venous catheter insertion into the internal jugular vein for ≥ 48 h. CRT was stratified into early (within 7 days) and late (days 8–14) thromboses. Multivariate analyses using logistic regression models clarified the relationships between early- and late-CRT risks and skin antiseptic and catheter site dressing combinations. CRT occurred in 74 of 134 patients (55%), including 52 with early CRT and 22 with late CRT. Patients receiving CGCD had a significantly lower incidence of early CRT than those receiving PITD (odds ratio = 0.18; 95% confidence interval = 0.07–0.45, p  < .001). No significant association was evident between using CGCD and late CRT (p  = .514). Compared to PITD, CGCD reduced the CRT risk over 7 days in critically ill patients. UMIN Clinical Trials Registry: UMIN000037492.


Sign in / Sign up

Export Citation Format

Share Document